Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,403 across all filing types
Latest filing 2019-04-26 AGM Information
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Special Business Approved at AGM
AGM Information Classification · 99% confidence The document explicitly details the 'RESOLUTIONS' passed at an 'Annual General Meeting' (AGM) held on 'Friday 26 April 2019'. It lists specific resolutions (8 through 12) concerning the authorization for directors to allot shares, rights issues, and share purchases, which are typical agenda items for an AGM. Since the document contains the results and content of the meeting itself, it is classified as AGM Information.
2019-04-26 English
Notice of AGM
AGM Information Classification · 98% confidence The document is a short announcement (1808 characters) dated April 25, 2019, titled 'NOTICE OF AGM'. It explicitly states that the 2019 Annual General Meeting details and related documents (Annual Report, Form of Proxy) have been 'posted or made available to shareholders'. According to Rule 2 (The 'MENU VS MEAL' Rule), when a document announces the publication or availability of other reports rather than being the report itself, it should be classified as a Report Publication Announcement (RPA). The presence of the RNS Number and the closing statement confirming the information is provided by RNS further supports this being a regulatory announcement about published materials, not the full report itself.
2019-04-25 English
Final Results
Annual Report Classification · 100% confidence The document is titled 'Annual Report' for Zegona Communications PLC for the year ended 31 December 2018. It contains a Chairman's Statement, Strategic Report, and Business and Financial Review, which are core components of a full annual report. Although it starts with an RNS header, the content provided is the full annual report document itself, not just an announcement of its publication. FY 2018
2019-04-25 English
LYNPARZA APPROVED IN EU FOR THE TREATMENT OF GERMLINE BRCA-MUTATED HER2-NEGATIVE
Regulatory Filings
2019-04-10 English
Hardman & Co Research: Global Pharmaceuticals: 2018 industry sales
Regulatory Filings Classification · 99% confidence The document is a brief announcement dated April 9, 2019, from 'Hardman & Co Research' regarding their publication titled 'Global Pharmaceuticals: 2018 industry sales'. It summarizes the content of the research (industry statistics, drug database updates, top company rankings) and explicitly provides a link to the 'full report'. Since the document itself is short (3776 characters) and serves primarily to announce the availability and content summary of a separate, detailed report, it fits the definition of a Report Publication Announcement (RPA) according to the 'MENU VS MEAL' rule. It is not the comprehensive financial report (10-K or IR) itself, nor is it a standard regulatory filing like an ER or MRQ.
2019-04-09 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by AstraZeneca PLC. It details a change in the percentage of voting rights held by Investor AB. This is a classic 'Major Shareholding Notification' (MRQ) as it reports a person or entity crossing a specific ownership threshold in a company's shares.
2019-04-04 English

Browse filings by year

34 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.